Mcl-1 modulating compounds for cancer treatment

Laurent Poulain; Anne-Sophie Voisin-Chiret; Jana Sopkova de Oliveira Santos; Ronan Bureau; Grégory Burzicki; Marcella de Giorgi; Serge Perato; Jade Fogha; Sylvain Rault; Philippe Juin; Fabien Gautier

Patents Year : 2019

Mcl-1 modulating compounds for cancer treatment

, , , , , , , , , (1) , (1)

1

Laurent Poulain

Function : Author
PersonId : 759147
ORCID : 0000-0002-9128-7881

Anne-Sophie Voisin-Chiret

Function : Author
PersonId : 767482
ORCID : 0000-0001-5564-2244
IdRef : 083367578

Jana Sopkova de Oliveira Santos

Function : Author

Ronan Bureau

Function : Author
PersonId : 754457
IdHAL : ronan-bureau
ORCID : 0000-0001-9404-8117
IdRef : 081232047

CV

Grégory Burzicki

Function : Author

Marcella de Giorgi

Function : Author

Serge Perato

Function : Author

Jade Fogha

Function : Author
PersonId : 770301
ORCID : 0000-0001-5512-544X

Sylvain Rault

Function : Author

Philippe Juin

Function : Author
PersonId : 182574
IdHAL : philippe-paul-juin
IdRef : 122068688

Stress Adaptation and Tumor Escape in Breast Cancer

Fabien Gautier

Function : Author

Stress Adaptation and Tumor Escape in Breast Cancer

Domains

Life Sciences [q-bio] Cancer

Elizabeth Bernardo : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02545394

Submitted on : Friday, April 17, 2020-9:15:32 AM

Last modification on : Wednesday, November 23, 2022-6:10:04 PM

Dates and versions

inserm-02545394 , version 1 (17-04-2020)

Identifiers

HAL Id : inserm-02545394 , version 1

Cite

Laurent Poulain, Anne-Sophie Voisin-Chiret, Jana Sopkova de Oliveira Santos, Ronan Bureau, Grégory Burzicki, et al.. Mcl-1 modulating compounds for cancer treatment. United States, Patent n° : US 20170071921 A1. 2019. ⟨inserm-02545394⟩

Mcl-1 modulating compounds for cancer treatment

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share